Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial

Arsenic trioxide (ATO) is synergistic with ascorbic acid (AA) and melphalan against myeloma both in vitro and in vivo. The aim of this randomized phase II trial was to determine the safety and efficacy of a combination of ATO, melphalan, and AA as preparative regimen in 48 patients undergoing autolo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Qazilbash, Muzaffar H., Saliba, Rima M., Nieto, Yago, Parikh, Gaurav, Pelosini, Matteo, Khan, Fatima B., Jones, Roy B., Hosing, Chitra, Mendoza, Floralyn, Weber, Donna M., Wang, Michael, Popat, Uday, Alousi, Amin, Anderlini, Paolo, Champlin, Richard E., Giralt, Sergio
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112362/
https://ncbi.nlm.nih.gov/pubmed/19041063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.09.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados